Innoviva Inc. (INVA)
NASDAQ: INVA
· Real-Time Price · USD
18.57
-0.01 (-0.05%)
At close: May 09, 2025, 3:59 PM
18.56
-0.05%
After-hours: May 09, 2025, 04:05 PM EDT
-0.05% (1D)
| Bid | 18.01 |
| Market Cap | 1.17B |
| Revenue (ttm) | 365.62M |
| Net Income (ttm) | 23.39M |
| EPS (ttm) | 0.36 |
| PE Ratio (ttm) | 51.58 |
| Forward PE | 10.67 |
| Analyst | Buy |
| Ask | 19 |
| Volume | 237,663 |
| Avg. Volume (20D) | 857,647 |
| Open | 18.62 |
| Previous Close | 18.58 |
| Day's Range | 18.39 - 18.67 |
| 52-Week Range | 15.16 - 21.28 |
| Beta | 0.36 |
About INVA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol INVA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for INVA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
2 months ago · businesswire.com
Innoviva to Participate in the Barclays 27th Annual Global Healthcare ConferenceBURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious ...
